FDA Panel Discusses Low Dose Moderna COVID Shots for Boosters | WGN Radio 720

US health advisers are discussing whether millions of Moderna-vaccinated Americans need to get booster shots — this time using half the original dose.

Millions of people who took their first Pfizer shot at least six months ago have already got a booster for that brand. On Thursday, a Food and Drug Administration adviser evaluated evidence that Moderna boosters should also be provided — and on Friday, they address the same question for Johnson & Johnson vaccinated people.

U.S. officials have identified 66 million unvaccinated Americans to be immunized, the ones most at risk due to the burning of highly contagious delta variants of the coronavirus nationwide. It emphasizes that shooting is a priority.

“It’s important to remember that vaccines provide strong protection against serious consequences, such as hospitalization and death from COVID-19,” said Dr. Peter Marks, FDA’s Head of Vaccines.

However, Marks also said that all three coronavirus vaccines used in the United States have been shown to have weakened protection against mild infections. It will “minimize confusion” for the general public.

Moderna is seeking FDA approval for boosters that are used in the same way as Pfizer. For people over 65 years of age, or for adults with other health problems, work, or living conditions at high risk of serious coronavirus-dose after the last 6 months or more.

The FDA will use the advisor’s recommendations when deciding whether to approve the Moderna booster. If so, there is yet another hurdle: next week, a panel convened by the Centers for Disease Control and Prevention will provide more details on who should get it.

The first two Moderna shots that everyone receives each contain 100 micrograms of vaccine. However, Moderna states that one 50 microgram shot is sufficient for boosters. According to the company, this will reduce unpleasant firing reactions such as fever and pain, while increasing the number of vaccines available for global supply.

A Moderna study of 344 people found that booster doses spurred a major leap in virus-fighting antibodies, including antibodies that could target delta mutants.

When Thursday’s deliberations began, FDA advisors quickly highlighted one confusing issue: people with a severely weakened immune system already get a third full-dose Moderna vaccine shortly after the first vaccination. You can-so the question is whether they should also qualify as boosters, this will be their fourth dose.


The Associated Press’s Department of Health Sciences is supported by the Department of Science Education at the Howard Hughes Medical Institute. AP is solely responsible for all content.

FDA Panel Discusses Low Dose Moderna COVID Shots for Boosters | WGN Radio 720

Source link FDA Panel Discusses Low Dose Moderna COVID Shots for Boosters | WGN Radio 720

Related Articles

Back to top button